Sage Therapeutics Inc (SAGE) Event Aug. 02, 2022, 00:00 UTC (66% Neutral) Sage Therapeutics, Inc. (SAGE) Reports Net Loss for 2022-06-30 Full text
Register to leave comments News bot Oct. 29, 2025, 10:27 a.m. 🏢 Sage Therapeutics Inc (SAGE) - Form 10-Q Quarterly Report Quarterly financial filing submitted to the SEC 📋 Filing Information 📄 Form Type: 10-Q 📅 Filing Date: 2022-08-02 📊 Period of Report: 2022-06-30 ⏰ Accepted: N/A 📊 Key Financial Metrics (Period-over-Period Comparison) Metric Current Period Previous Period Change ($) Change (%) Trend Net Income/Loss $-203.01M $-248.31M $45.31M +18.25% 📉 Total Assets $1.83B $1.60B $223.91M +13.98% 📈 Total Liabilities $96.26M $97.14M $-884.00K -0.91% ↘️ Stockholders' Equity $1.50B $-1.74B $3.25B +186.27% 📈 Operating Income/Loss $-204.53M $-204.53M N/A +0.00% ➡️ R&D Expense $1.00M $124.23M $-123.23M -99.20% 📈 SG&A Expense $83.19M $83.19M N/A +0.00% ➡️ Revenues $1.10B N/A $1.10B +0.00% ➡️ Earningspersharebasic $-3.47 $-4.20 $0.73 +17.38% 📈 Earningspersharediluted $-3.47 $-4.20 $0.73 +17.38% 📈 📈 Financial Trend Analysis 🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities 📎 View Full 10-Q Filing on SEC.gov Access the complete official filing document
🏢 Sage Therapeutics Inc (SAGE) - Form 10-Q Quarterly Report
📋 Filing Information
Key Financial Metrics (Period-over-Period Comparison)
Financial Trend Analysis
🔻 Reported net loss for the period • 🏦 Strengthened balance sheet with assets growing faster than liabilities
📎 View Full 10-Q Filing on SEC.gov
Access the complete official filing document